BSG and diabetes mellitus: CD147 is essential for diabetes-associated recombinant tissue-plasminogen activator (rt-PA)-induced hemorrhagic transformation, and reduced CD147 glycosylation is an encouraging therapy for neurovascular-unit repair following rt-PA treatment of diabetes patients (108).